Biosensors soars on CE-mark for Axxion DES (drug-eluting stent)
This article was originally published in Clinica
Executive Summary
Shares in Biosensors International surged after the company revealed on July 12 it had CE-marked sale in Europe its first product for the highly lucrative drug-eluting stent (DES) arena.